IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,425,257 | +241.7% | 200,872 | +294.8% | 0.00% | – |
| Q2 2023 | $3,050,585 | -21.4% | 50,877 | -35.2% | 0.00% | -100.0% |
| Q1 2023 | $3,882,128 | -68.6% | 78,522 | -63.8% | 0.00% | -66.7% |
| Q4 2022 | $12,377,798 | -16.2% | 216,888 | -31.1% | 0.00% | 0.0% |
| Q3 2022 | $14,778,000 | +269.8% | 314,802 | +193.9% | 0.00% | +200.0% |
| Q2 2022 | $3,996,000 | +123.7% | 107,100 | +79.3% | 0.00% | – |
| Q1 2022 | $1,786,000 | +330.4% | 59,726 | +392.7% | 0.00% | – |
| Q4 2021 | $415,000 | -50.3% | 12,123 | -46.2% | 0.00% | – |
| Q3 2021 | $835,000 | -58.3% | 22,528 | -56.1% | 0.00% | – |
| Q2 2021 | $2,004,000 | -8.5% | 51,310 | -0.2% | 0.00% | -100.0% |
| Q1 2021 | $2,189,000 | – | 51,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |